Sun, Mar 1, 2015, 2:04 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Navidea Biopharmaceuticals, Inc Message Board

  • investor1579 investor1579 Jul 8, 2012 11:46 AM Flag

    14.5 million shares short

    Iv'e checked and there is very little stock available to be borrowed. That means, not only will it be very difficult for the shorts to be able to continually pressure the stock, but as less stock becomes available to borrow, the shorts will be squeezed. It appears that they have achieved a tremendous upgrade in talent in reference to management. This combined with a probable FDA approval will cause an enormous short squeeze. 14.5 million shares short could move the stock points beyond where it would ordinarily go. The recent action shows that the shorts are on the run. As the stock rises, the pressure on the shorts is enourmous. When you go long, you can only lose what you invest. When you go short, the potential losses are unlimited. I'm sure the clearing firms where the short positions are held are getting nervous, therefore, they are probably starting to call in the stock. This will be fun to watch.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
NAVB
1.62-0.05(-2.99%)Feb 27 4:07 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.